Return On Equity of Cogent Biosciences, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cogent Biosciences, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Cogent Biosciences, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -126%, a 78% decline year-over-year.
  • Cogent Biosciences, Inc. annual Return On Equity for 2024 was -75%, a 10% decline from 2023.
  • Cogent Biosciences, Inc. annual Return On Equity for 2023 was -68%, a 28% decline from 2022.
  • Cogent Biosciences, Inc. annual Return On Equity for 2022 was -53%, a 57% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Cogent Biosciences, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -126% -55% -78% 01 Jul 2025 30 Sep 2025
Q2 2025 -120% -53% -80% 01 Apr 2025 30 Jun 2025
Q1 2025 -93% -29% -45% 01 Jan 2025 31 Mar 2025
Q4 2024 -75% -7% -10% 01 Oct 2024 31 Dec 2024
Q3 2024 -71% -8% -13% 01 Jul 2024 30 Sep 2024
Q2 2024 -67% -11% -19% 01 Apr 2024 30 Jun 2024
Q1 2024 -64% -9% -17% 01 Jan 2024 31 Mar 2024
Q4 2023 -68% -15% -28% 01 Oct 2023 31 Dec 2023
Q3 2023 -63% -13% -27% 01 Jul 2023 30 Sep 2023
Q2 2023 -56% -9% -18% 01 Apr 2023 30 Jun 2023
Q1 2023 -54% -10% -21% 01 Jan 2023 31 Mar 2023
Q4 2022 -53% -19% -57% 01 Oct 2022 31 Dec 2022
Q3 2022 -50% -23% -84% 01 Jul 2022 30 Sep 2022
Q2 2022 -48% +7% +13% 01 Apr 2022 30 Jun 2022
Q1 2022 -45% +25% +36% 01 Jan 2022 31 Mar 2022
Q4 2021 -34% +82% +71% 01 Oct 2021 31 Dec 2021
Q3 2021 -27% +422% +94% 01 Jul 2021 30 Sep 2021
Q2 2021 -55% +33% +37% 01 Apr 2021 30 Jun 2021
Q1 2021 -70% +13% +16% 01 Jan 2021 31 Mar 2021
Q4 2020 -116% -31% -36% 01 Oct 2020 31 Dec 2020
Q3 2020 -449% -353% -367% 01 Jul 2020 30 Sep 2020
Q2 2020 -88% -12% -16% 01 Apr 2020 30 Jun 2020
Q1 2020 -83% -21% -34% 01 Jan 2020 31 Mar 2020
Q4 2019 -85% +11% +12% 01 Oct 2019 31 Dec 2019
Q3 2019 -96% +287% +75% 01 Jul 2019 30 Sep 2019
Q2 2019 -76% 01 Apr 2019 30 Jun 2019
Q1 2019 -62% 01 Jan 2019 31 Mar 2019
Q4 2018 -96% 01 Oct 2018 31 Dec 2018
Q3 2018 -383% 01 Jul 2018 30 Sep 2018

Cogent Biosciences, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -75% -7% -10% 01 Jan 2024 31 Dec 2024
2023 -68% -15% -28% 01 Jan 2023 31 Dec 2023
2022 -53% -19% -57% 01 Jan 2022 31 Dec 2022
2021 -34% +82% +71% 01 Jan 2021 31 Dec 2021
2020 -116% -31% -36% 01 Jan 2020 31 Dec 2020
2019 -85% +11% +12% 01 Jan 2019 31 Dec 2019
2018 -96% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.